Methadone
14
3
3
9
Key Insights
Highlights
Success Rate
82% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
14.3%
2 terminated out of 14 trials
81.8%
-4.7% vs benchmark
43%
6 trials in Phase 3/4
11%
1 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (14)
Divided or Single Exposure (DOSE) Study
Methadone in Adults Undergoing Cardiac Surgery
Perioperative Methadone Compared to Placebo in Elderly Hip Fracture Patients
Evaluating Tetrahydrocannabinol as an Adjunct to Opioid Agonist Therapy
Methadone for Spinal Fusion Surgery.
Anti-retroviral Therapy, Medications for Opioid Use Disorder, Opioids and HIV Infection - Study 1
Perioperative Methadone in Hip Fracture Patients
Slow-Release Oral Morphine for the Treatment of Opioid Use Disorder
Attention Training for Opioid-maintained Cocaine Users
Skills Based Counseling for Adherence and Depression in HIV+ Methadone Patients - 1
Comparison of Two Counseling Induction Strategies
Initialization of Methadone in Primary Care, Randomized Intervention Research for Preventing HCV Transmission Practices
Improving Methadone Maintenance Treatment Compliance and Outcomes in China
Recovery Management Intervention in China